Cargando…
Modulation of Glycoprotein VI and Its Downstream Signaling Pathways as an Antiplatelet Target
Antiplatelet therapy aims to reduce the risk of thrombotic events while maintaining hemostasis. A promising current approach is the inhibition of platelet glycoprotein GPVI-mediated adhesion pathways; pathways that do not involve coagulation. GPVI is a signaling receptor integral for collagen-induce...
Autor principal: | Fuentes, Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456422/ https://www.ncbi.nlm.nih.gov/pubmed/36077280 http://dx.doi.org/10.3390/ijms23179882 |
Ejemplares similares
-
Beyond antiplatelets: The role of glycoprotein VI in ischemic stroke
por: Induruwa, Isuru, et al.
Publicado: (2016) -
Antiplatelet Activity of Tussilagone via Inhibition of the GPVI Downstream Signaling Pathway in Platelets
por: Zhou, Jing, et al.
Publicado: (2020) -
Antiplatelet Activity of Tetramethylpyrazine via Regulation of the P2Y12 Receptor Downstream Signaling Pathway
por: Guan, Baoyi, et al.
Publicado: (2022) -
Regulation of Key Antiplatelet Pathways by Bioactive Compounds with Minimal Bleeding Risk
por: Fuentes, Eduardo, et al.
Publicado: (2021) -
Glutamate, Glutamate Receptors, and Downstream Signaling Pathways
por: Willard, Stacey S., et al.
Publicado: (2013)